10 completed, 3 terminated, 2 active not recruiting. 15 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 15 | Completed 10, Terminated 3, Active not recruiting 2 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Endocyte: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer 225^Ac-PSMA-617, 68^Ga-PSMA-11 - Prostatic Neoplasms, Castration-Resistant | Phase 1 | Active not recruiting | Endocyte | 101 | 2021-04-01 | 2026-04-30 |
| Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy 177Lu-PSMA-617 - Prostatic Neoplasms | Phase 1 / Phase 2 | Active not recruiting | Peter MacCallum Cancer Centre, Australia | 20 | 2020-08-06 | 2024-11-08 |
| Imaging Activated Macrophages in the Lungs Ga-EC2115 - COPD | Phase 1 | Terminated | Vanderbilt University Medical Center | 13 | 2018-11-29 | 2021-08-11 |
| An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery EC1456, 99mTc-Etarfolatide - Ovary Cancer | Phase 1 | Completed | Endocyte | 3 | 2017-01-24 | 2019-02-07 |
| Phase 1 of EC1169 In Patients With Recurrent MCRPC EC1169, EC0652 - Prostate Cancer | Phase 1 | Completed | Endocyte | 40 | 2014-05-01 | 2019-02-07 |
| A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011) Vintafolide - Solid Tumor | Phase 1 | Terminated | Endocyte | 3 | 2014-02-01 | 2015-02-10 |
| Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors EC1456 and EC20 - Solid Tumors, Non Small Cell Lung Carcinoma | Phase 1 | Completed | Endocyte | 93 | 2013-10-01 | 2019-02-07 |
| Evaluation of the Biodistribution and Safety of 99mTC-Etarfolatide (EC20) in Normal Volunteers Etarfolatide (EC20) - Healthy | Phase 1 | Completed | Endocyte | 23 | 2013-04-01 | 2014-07-29 |
| A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) Vintafolide, Carboplatin, Paclitaxel - Advanced Cancer | Phase 1 | Terminated | Endocyte | 37 | 2012-12-01 | 2015-02-10 |
| Study of EC0489 for the Treatment of Refractory or Metastatic Tumors EC0489, Injection, EC20 - Cancer | Phase 1 | Completed | Endocyte | 65 | 2009-04-01 | 2012-08-08 |
| Study of EC0225 for the Treatment of Refractory or Metastatic Tumors EC0225, for Injection (Folic acid desacetylvinblastine hydrazide conjugate), 99mTC-EC20 (Folic acid-technetium 99m conjugate) - Cancer | Phase 1 | Completed | Endocyte | 77 | 2007-02-01 | 2012-03-09 |
| Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01) Vintafolide IV Bolus, Vintafolide IV Infusion - Cancer | Phase 1 | Completed | Endocyte | 32 | 2006-03-01 | 2014-12-19 |
| Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer EC90 (KLH-FITC), GPI-0100, EC17 (Folate-FITC) - Cancer | Phase 1 | Completed | Endocyte | 13 | 2005-09-01 | 2012-03-09 |
| Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer Tc 99m EC20 - Ovarian Cancer, Endometrial Cancer | Phase 1 | Completed | Endocyte | 12 | 2001-08-01 | 2023-06-22 |
| Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients Tc 99m EC20 - Ovarian Cancer, Healthy Volunteers | Phase 1 | Completed | Endocyte | 8 | 2000-08-01 | 2023-06-22 |
Neoplasms (5) · Ovarian Neoplasms (3) · Prostatic Neoplasms (3) · Neoplasm Metastasis (2) · Recurrence (2) · Carcinoma, Non-Small-Cell Lung (1) · Endometrial Neoplasms (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Prostatic Neoplasms, Castration-Resistant (1) · Pulmonary Disease, Chronic Obstructive (1) · Urogenital Neoplasms (1)
EC145 (2) · Folic Acid (2) · (225)Ac-PSMA-617 (1) · Carboplatin (1) · EC 0489 (1) · EC0225 (1) · GPI0100 (1) · Interferon-alpha (1) · Interleukin-2 (1) · Introns (1) · Leucovorin (1) · Paclitaxel (1) · Pluvicto (1) · WW Domain-Containing Oxidoreductase (1) · aldesleukin (1)
United States (11) · Australia (2) · Canada (1) · South Africa (1)
Alison Armour, MD (2) · Alison Armour, MB ChB, BSc, MSc, MD, MRCP (1) · Beth Safirstein, MD (1) · Declan Murphy (1) · James W. Fletcher, MD (1) · John Violet (1) · Michael S Hofman (1) · Richard A Messmann, MD, MHS, BSc (1) · Richard A Messmann, MD, MHS, MSc (1) · Richard A. Messmann, MD, MHS, MSc (1) · Timothy S Blackwell, MD (1) · Wael Harb, MD (1)